Matt Lamkin, JD

Matt Lamkin, JD
Associate Professor of Law
College of Law
Law
918-631-3989 College of Law Room law

Education

MA – University of Minnesota JD – Northwestern University School of Law AB – Princeton University

Bio

Matt Lamkin comes to the College of Law after two years as a Fellow at Stanford Law School's Center for Law and the Biosciences. Prior to entering academia, he was in private practice at Latham & Watkins, served as a law clerk to a federal judge, and worked as a policy advisor to the Mayor of Indianapolis. Matt holds an AB degree from Princeton University, an MA in Bioethics from the University of Minnesota, and a JD from Northwestern Law School. He has published extensively on legal and ethical issues in employer-sponsored health insurance, regulation of pharmaceutical marketing and physician prescribing, and the challenges presented by medical marijuana and the opioid epidemic. His interdisciplinary work has appeared in both law reviews and top journals of science, medicine, and ethics, including the New England Journal of Medicine, Bioethics, Scientific American, JAMA Psychiatry, the AMA Journal of Ethics, and others.

Research Interests

Professor Lamkin’s research explores the intersection of health care, law, and ethics, with a particular focus on how the growing tendency to view medical care as commerce is reshaping common conceptions of disease and disability, informed consent and personal responsibility, and the role of government in regulating medical care. His scholarship has analyzed legal and ethical issues in employer-sponsored health insurance, regulation of pharmaceutical marketing and physician prescribing, and the challenges presented by medical marijuana and the opioid epidemic. This interdisciplinary work has appeared in both law reviews and top journals of science, medicine, and ethics, including the New England Journal of Medicine, Bioethics, Scientific American, JAMA Psychiatry, the AMA Journal of Ethics, and others.

Teaching Interests

Torts
Constitutional Law
Health Law
Bioethics

Publications

Law Reviews

  • Physician as Double Agent — Conflicting Duties Arising from Employer-Sponsored Wellness Programs, 379 N. Eng. J. Med. 1297 (2018).

  • Avoiding Exploitation in Phase I Clinical Trials, (2017).

  • Involuntarily Committed Patients as Prisoners, 51 U. Rich. L. Rev. (2017).

  • Regulating Identity: Medical Regulation as Social Control, 2016 B.Y.U. L. Rev. 501 (2016).

  • Restrict the Recruitment of Involuntarily Committed Patients for Psychiatric Research, 73(4) JAMA Psych. 317 (2016).

  • Curing the Disobedient Patient: Medication Adherence Programs as Pharmaceutical Marketing Tools, (with Carl Elliot) 42 Journal of Law, Medicine & Ethics 492 (2014).

  • Matthew Lamkin & Carl Elliott, Curing the Disobedient Patient: Medication Adherence Programs as Pharmaceutical Marketing Tools, (with Carl Elliot) 42 Journal of Law, Medicine & Ethics 492 (2014).

  • Matthew Lamkin, Health Care Reform, Wellness Programs and the Erosion of Informed Consent, 101 Ky. L.J. 435 (2013).

  • Matthew Lamkin, Cognitive Enhancements and the Values of Higher Education, 20 Health Care Analysis 347 (2012).

  • Matthew Lamkin, Racist Appearance Standards and the Enhancements that Love Them: Norman Daniels and Skin-Lightening Cosmetics, 25 Bioethics 185 (2011).

  • Matthew Lamkin, The Rise and Impending Fall of Diagnosis as a Marker of Difference, 13 Virtual Mentor: AMA J. Ethics 896 (2011).

Journal Articles

  • Avoiding Exploitation in Phase I Clinical Trials, (2017).

Other

  • Don’t Treat Brain Boosting Like Athletic Doping, Chron. High. Educ. (February 27, 2011).

Courses Taught

  • Constitutional Law I
  • Medical Malpractice and Healthcare Liability
  • Seminar
  • Torts